Search Results - "Hasumi, Kenichiro"

Corrigendum to “Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells” [Neoplasia 39 (2023), 100893] by Shui, Yifang, Hu, Xin, Hirano, Hiroshi, Tsukamoto, Hirotake, Guo, Wen-Zhi, Hasumi, Kenichiro, Ijima, Fumihiro, Fujino, Masayuki, Li, Xiao-Kang

Get full text

Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells by Shui, Yifang, Hu, Xin, Hirano, Hiroshi, Tsukamoto, Hirotake, Guo, Wen-Zhi, Hasumi, Kenichiro, Ijima, Fumihiro, Fujino, Masayuki, Li, Xiao-Kang

“…•cPLs augments the anti-tumor immune responses.•cPLs changes the phenotype of TADCs from suppressive to promotive.•cPLs enhances the production of cytokine in…”
Get full text

Long-lasting complete remission in a patient with systemic metastases of recurrent breast cancer treated with cyclin-dependent kinases 4/6 inhibitors: a case report by Yoneto, Toshihiko, Hasumi, Kenichiro, Takahashi, Nobukazu, Seki, Nastuki, Takeda, Yasutaka, Yoshimoto, Takayuki

“…The prognosis for recurrence cases of hormone receptor-positive HER2-negative breast cancer remains poor, and treatment strategies that emphasize quality of…”
Get full text

A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma by Koch, Elias A T, Schaft, Niels, Kummer, Mirko, Berking, Carola, Schuler, Gerold, Hasumi, Kenichiro, Dörrie, Jan, Schuler-Thurner, Beatrice

“…Uveal melanoma (UM) is an orphan disease with a mortality of 80% within one year upon the development of metastatic disease. UM does hardly respond to…”
Get full text

Clinical response of advanced cancer patients to cellular immunotherapy and intensity-modulated radiation therapy by Hasumi, Kenichiro, Aoki, Yukimasa, Wantanabe, Ryuko, Mann, Dean L

“…Patients afflicted with advanced cancers were treated with the intratumoral injection of autologous immature dendritic cells (iDCs) followed by activated…”
Get full text

Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity by Voskens, Caroline J, Watanabe, Ryuko, Rollins, Sandra, Campana, Dario, Hasumi, Kenichiro, Mann, Dean L

“…The possibility that autologous NK cells could serve as an effective treatment modality for solid tumors has long been considered. However, implementation is…”
Get full text

Selective boron delivery by intra-arterial injection of BSH-WOW emulsion in hepatic cancer model for neutron capture therapy by Yanagie, Hironobu, Dewi, Novriana, Higashi, Syushi, Ikushima, Ichiro, Seguchi, Koji, Mizumachi, Ryoji, Murata, Yuji, Morishita, Yasuyuki, Shinohara, Atsuko, Mikado, Shoji, Yasuda, Nakahiro, Fujihara, Mitsuteru, Sakurai, Yuriko, Mouri, Kikue, Yanagawa, Masashi, Iizuka, Tomoya, Suzuki, Minoru, Sakurai, Yoshinori, Masunaga, Shin-Ichiro, Tanaka, Hiroki, Matsukawa, Takehisa, Yokoyama, Kazuhito, Fujino, Takashi, Ogura, Koichi, Nonaka, Yasumasa, Sugiyama, Hirotaka, Kajiyama, Tetsuya, Yui, Sho, Nishimura, Ryohei, Ono, Koji, Takamoto, Sinichi, Nakajima, Jun, Ono, Minoru, Eriguchi, Masazumi, Hasumi, Kenichiro, Takahashi, Hiroyuki

“…Boron neutron-capture therapy (BNCT) has been used to inhibit the growth of various types of cancers. In this study, we developed a BSH-entrapped…”
Get full text

Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding β₂-microglobulin genes by Hsieh, Chin-Hsuan, Hsu, Ya-Jan, Chang, Chien-Chung, Liu, Hsin-Chun, Chuang, Kun-Lung, Chuang, Cheng-Keng, Pang, See-Tong, Hasumi, Kenichiro, Ferrone, Soldano, Liao, Shuen-Kuei

“…In renal cell carcinoma (RCC), HLA class I downregulation has been found in about 40% of the lesions examined. Since only scanty information is available about…”
Get full text

Corrigendum to "Combined phospholipids adjuvant augments anti-tumor immune responses through activated tumor-associated dendritic cells" Neoplasia 39 (2023), 100893 by Shui, Yifang, Hu, Xin, Hirano, Hiroshi, Tsukamoto, Hirotake, Guo, Wen-Zhi, Hasumi, Kenichiro, Ijima, Fumihiro, Fujino, Masayuki, Li, Xiao-Kang

Get full text

Case report: two cases of extremely rare primary pure squamous cell carcinoma of the breast by Yoneto, Toshihiko, Hasumi, Kenichiro, Yoshimoto, Takayuki, Takahashi, Nobukazu, Takeda, Yasutaka

“…Since primary pure squamous cell carcinoma of the breast is a rare disease, few reports describe the characteristic findings on performing preoperative imaging…”
Get full text

β-glucan from Aureobasidium pullulans augments the anti-tumor immune responses through activated tumor-associated dendritic cells by Shui, Yifang, Hu, Xin, Hirano, Hiroshi, Kusano, Kisato, Tsukamoto, Hirotake, Li, Mengquan, Hasumi, Kenichiro, Guo, Wen-Zhi, Li, Xiao-Kang

“…•AP-BG augments the anti-tumor immune responses.•AP-BG changes the phenotype of TADCs from suppressive to promotive.•AP-BG enhances the production of cytolytic…”
Get full text

A patient with stage IIIB advanced breast cancer who is still alive 24 years after surgery: a case report and remarks on the treatment strategies by Yoneto, Toshihiko, Hasumi, Kenichiro, Fujii, Yuzo, Takahashi, Nobukazu, Seki, Natsuki, Yoshimoto, Takayuki, Takeda, Yasutaka

Get full text

Hypoxic Conditions Promote Gemcitabine Sensitivity in a Pancreatic Cancer Stem Cell Line by Imaizumi, Akira, Onishi, Hideya, Yamasaki, Akio, Kawamoto, Makoto, Umebayashi, Masayo, Morisaki, Takashi, Hasumi, Kenichiro

“…Development of an effective therapeutic strategy for refractory pancreatic cancer must consider whether chemosensitivity can be induced in chemoresistant…”
Get full text

Sugar-carrying Polystyrenes Facilitate Harvesting of APCs from MLRs: Possible Application of Sugar-carrying Polystyrenes to Immunotherapy by Imaizumi, Akira, Onishi, Hideya, Yamasaki, Akio, Kawamoto, Makoto, Morisaki, Takashi, Goto, Mitsuaki, Iwama, Masamichi, Akaike, Toshihiro, Hasumi, Kenichiro

“…Antigen-presenting cells (APCs) play a pivotal role in cancer immunotherapy. APCs in conventionally used flasks are harvested by enzymatic digestion or cell…”
Get full text

Combining Conventional Therapies with Intratumoral Injection of Autologous Dendritic Cells and Activated T Cells to Treat Patients with Advanced Cancers by Mann, Dean L., Celluzzi, Christina M., Hankey, Kim G., Harris, Kristina M., Watanabe, Ryuko, Hasumi, Kenichiro

“…Dendritic cells (DCs) are potent antigen‐presenting cells that have been used in cancer immunotherapy. To take advantage of the ability of DCs to acquire…”
Get full text

Therapeutic response in patients with advanced malignancies treated with combined dendritic cell-activated T cell based immunotherapy and intensity-modulated radiotherapy by Hasumi, Kenichiro, Aoki, Yukimasa, Watanabe, Ryuko, Hankey, Kim G, Mann, Dean L

“…Successful cancer immunotherapy is confounded by the magnitude of the tumor burden and the presence of immunoregulatory elements that suppress an immune…”
Get full text

Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding [beta]2-microglobulin genes by Hsieh, Chin-hsuan, Hsu, Ya-jan, Chang, Chien-chung, Liu, Hsin-chun, Chuang, Kun-lung, Chuang, Cheng-keng, Pang, See-tong, Hasumi, Kenichiro, Ferrone, Soldano, Liao, Shuen-kuei

“…In renal cell carcinoma (RCC), HLA class I downregulation has been found in about 40% of the lesions examined. Since only scanty information is available about…”
Get full text

Total HLA class I loss in a sarcomatoid renal carcinoma cell line caused by the coexistence of distinct mutations in the two encoding beta 2-microglobulin genes by Hsieh, Chin-Hsuan, Hsu, Ya-Jan, Chang, Chien-Chung, Liu, Hsin-Chun, Chuang, Kun-Lung, Chuang, Cheng-Keng, Pang, See-Tong, Hasumi, Kenichiro, Ferrone, Soldano, Liao, Shuen-Kuei

“…In renal cell carcinoma (RCC), HLA class I downregulation has been found in about 40% of the lesions examined. Since only scanty information is available about…”
Get full text

Products of anti-CD3/anti-CD28 activated lymphocytes induce differentiation and maturation of dendritic cells and have adjuvant-like activity in vitro and in vivo by Harris, Kristina M, Lenz, Petra, Hankey, Kim G, MacVittie, Thomas, Farese, Ann, Nakajima, Kaori, Hasumi, Kenichiro, Mann, Dean L

“…Abstract Dendritic cells (DC) orchestrate immune responses under direction of cytokines/chemokines in their microenvironment. To investigate the influence of…”
Get full text

Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy by SATO, Takami, TERAI, Mizue, YASUDA, Rie, WATANABE, Ryuko, BERD, David, MASTRANGELO, Michael J, HASUMI, Kenichiro

“…Interactions between dendritic cells (DCs) and activated T cells are critically important for the establishment of an effective immune response. To develop the…”
Get full text